Skip to main content
. 2021 Aug 3;3(1):vdab102. doi: 10.1093/noajnl/vdab102

Figure 4.

Figure 4.

(A) Patients with newly diagnosed GBM on Arms A and B with tumor volumes below 25 cm3 had a significantly longer median OS than those above 25 cm3 (2.0 vs 0.8 years; P = .006 respectively). (B) Patients on Arms A and B with EGFR amplified tumor volumes below 25 cm3 had improved survival than those above 25 cm3 (1.8 vs 0.8 years respectively, P = .28)